While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to continue.

Smaller acquisitions and disciplined pricing are proving to be big benefits to a wider number of companies ...

This oncology-focused biotech, advancing multiple clinical-stage therapeutics, just reported a notable insider sale in recent ...

After initiating a wind-down more than 18 months ago and exploring liquidation, Galera Therapeutics has found a path forward ...

The Spanish government is taking its chance on Boston’s booming life sciences hub, opening an Economic and Trade Commission in the city, while creating a $200 million venture capital fund to support ...

First commercial agreement with a top 5 global pharmaceutical company anchors a growing pipeline of enterprise discussions; runway secured into late 2027GAITHERSBURG, Md., April 13, 2026 (GLOBE ...

Iovance Biotherapeutics argues that there is a meaningful opportunity here of more than 8,000 patients diagnosed annually in ...

Sana Biotechnology Inc. (NASDAQ:SANA) is one of the best healthcare penny stocks to buy according to hedge funds. On March 16 ...

The companies Earendil Labs, Teva Pharmaceuticals, and Solid Biosciences bagged the biggest biotech funding rounds overall in ...

Discover what were the top biotech deals that were signed in March 2026. From small molecules to antibodies, M&A activity was high.

The Spanish government is launching a venture capital fund with a goal of raising $200 million to invest in biotechnology ...